ADC biotech Ona Therapeutics secures $86.6M in Series B raise
Barcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic. CEO Valerie Vanhooren told Endpoints News in an interview that the cash should provide two-and-a-half ...
Valerie Vanhooren, Ona Therapeutics CEO June 4, 2026 03:00 AM EDTUpdated 06:15 AM FinancingStartups ADC biotech Ona Therapeutics secures $86.6M in Series B raise Ayisha Sharma News Reporter Barcelona-based Ona Therapeutics has raised $86.6 million in a Series B round to advance two ADC candidates into the clinic. CEO Valerie Vanhooren told Endpoints … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER
comments(0)
5-min edit window · permanent after that